Core Scientific

CORZ

Market cap $4.97B

Overview Fund Activity

16.27 USD

+0.09

0.56%

At close Updated Sep 17, 4:00 PM EDT

Pre-market

After hours

16.33

+0.06

0.37%

1 day

0.56%

5 days

1.5%

1 month

11.98%

3 months

36.84%

6 months

85.73%

Year to date

12.36%

1 year

41.72%

5 years

372.97%

10 years

372.97%

About: Core Scientific Inc is engaged in designing, building and operating digital infrastructure for high-performance computing. The business operates in three operating segments; Digital Asset Self-Mining, consisting of performing digital asset mining for the own account, Digital Asset Hosted Mining, consisting of providing hosting services to third parties for digital asset mining, and HPC Hosting, consisting of providing hosting services to third parties for graphics processing unit (GPU) based HPC hosting operations. The majority of revenue is derived from the Digital Asset Self-Mining Segment.

Employees: 325

Technology Software - Infrastructure

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 6 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

299% more call options, than puts

Call options by funds: $1.88B | Put options by funds: $470M

147% more capital invested

Capital invested by funds: $1.79B [Q1] → $4.41B (+$2.63B) [Q2]

94% more repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 81

63% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 63

33% more funds holding in top 10

Funds holding in top 10: 18 [Q1] → 24 (+6) [Q2]

11% more funds holding

Funds holding: 328 [Q1] → 364 (+36) [Q2]

6.91% more ownership

Funds ownership: 79.92% [Q1] → 86.82% (+6.91%) [Q2]

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$15

8% downside

Avg. target

$17.67

9% upside

High target

$22

35% upside

6 analyst ratings

2 positive

33%

4 neutral

67%

0 negative

0%

Roth Capital Darren Aftahi	$17	Neutral Maintained	22 Aug 2025
Macquarie Paul Golding	$15	Neutral Maintained	19 Aug 2025
Jefferies Jonathan Petersen	$22	Buy Maintained	18 Aug 2025
JMP Securities Greg Miller	$15	Market Perform Downgraded	14 Jul 2025
BTIG Gregory Lewis	$20	Neutral Downgraded	7 Jul 2025
Canaccord Genuity Joseph Vafi	$17	Buy Maintained	27 Jun 2025

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about CORZ published over the past 30 days

Johnson Fistel Investigates Fairness of Proposed Sale of Core Scientific

SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is continuing its investigation into whether the board members of Core Scientific, Inc. (NasdaqGS: CORZ) breached their fiduciary duties in connection with the proposed sale of the company to CoreWeave, Inc. (NasdaqGS: CRWV).

Johnson Fistel Investigates Fairness of Proposed Sale of Core Scientific

CoreWeave Faces a Fight to Buy Core Scientific Amid Stock Shifts. Why a Deal Needs to Be Done.

CoreWeave stock has dropped back, putting its deal for Core Scientific at risk. A renegotiation seems likely.

CoreWeave Faces a Fight to Buy Core Scientific Amid Stock Shifts. Why a Deal Needs to Be Done.

Zacks Investment Research

Core Scientific, Inc. (CORZ) Upgraded to Buy: What Does It Mean for the Stock?

Core Scientific, Inc. (CORZ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Core Scientific, Inc. (CORZ) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Investment Research

Core Scientific, Inc. (CORZ) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Core Scientific, Inc. (CORZ) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Core Scientific, Inc. (CORZ) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks Investment Research

Core Scientific, Inc. (CORZ) Reports Q2 Loss, Lags Revenue Estimates

Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.04 per share a year ago.

Core Scientific, Inc. (CORZ) Reports Q2 Loss, Lags Revenue Estimates

The Motley Fool

Core Scientific Revenue Falls 44 Percent

Core Scientific Revenue Falls 44 Percent

Core Scientific Revenue Falls 44 Percent

Core Scientific Announces Fiscal Second Quarter 2025 Results

AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced financial results for the fiscal second quarter of 2025. Fiscal Second Quarter 2025 Financial Results Total revenue was $78.6 million compared to $141.1 million in the second quarter of 2024. Digital asset self-mining revenue was $62.4 million, down from $110.7 million in the prior-year period. The decline was pri.

Core Scientific Announces Fiscal Second Quarter 2025 Results

Shareholder Alert: The Ademi Firm Investigates Whether Core Scientific, Inc. Is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Core Scientific (NYSE: CORZ) for possible breaches of fiduciary duty and other violations of law in its transaction with CoreWeave. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Core Scientific will receive 0.1235 newly issued shares of CoreWeave Class A common.

Shareholder Alert: The Ademi Firm Investigates Whether Core Scientific, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Core Scientific's largest shareholder to vote against sale to CoreWeave

Two Seas Capital, the largest shareholder of Core Scientific , issued an open letter on Thursday saying it would vote against the company's proposed sale to CoreWeave.

Core Scientific's largest shareholder to vote against sale to CoreWeave

Two Seas Capital, Core Scientific's Largest Active Shareholder, Announces Intention to Vote Against the Proposed Sale to CoreWeave

Issues Open Letter to Core Scientific Shareholders Outlining Its Belief that the Proposed Transaction Materially Undervalues Core Scientific and Unnecessarily Exposes Shareholders to Substantial Economic Risk NEW YORK , Aug. 7, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ: CORZ), today announced its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ: CRWV) on the terms announced on July 7, 2025. Two Seas also released the following open letter to fellow Core Scientific shareholders explaining why it opposes the transaction.

Two Seas Capital, Core Scientific's Largest Active Shareholder, Announces Intention to Vote Against the Proposed Sale to CoreWeave

See News Rankings

Charts implemented using Lightweight Charts™